Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) announced results for the fourth quarter and year ended December 31, 2009.
* Cubist acquired Calixa Therapeutics Inc. in December
* Operating income grew 52% over 2008
* Total net revenues for 2009 increased 30% over 2008
Related posts
Biomet Announces Financial [...]










































